How to ensure quantum algorithms are purpose-built for business value creation
It’s a key time for quantum technology and quantum computing; success awaits those who ensure quantum algorithms are purpose-built for business value creation
Accelerating the adoption of omics in clinical medicine
Cambridge Consultants is spearheading efforts to realise the clinical potential of omics through deep tech in digital microfluidics, photonics and quantum sensors
最も投資余地があるメドテックイノベーションの機会
This is the year to put medtech investment to work. With macroeconomics improving, inflation easing and organizations stabilizing, now is the time to light the powder.
Cracking genomics needs biology and engineering to find a common language
The first company to deploy cost-effective genomic measurements in mainstream medicine will not only transform healthcare, but also create lasting business value. But why has no-one cracked it yet?
The precision medicine industry must work together to transform rare disease treatment
Precision medicine is leading to transformative patient treatments – but industry collaboration is needed to make sure patients with rare diseases are not left behind.
Metamorphosis: How converging deep tech will propel business in the new bioeconomy
バイオテクノロジーや合成生物学などの新たなディープテックが、エキサイティングな新しいバイオエコノミーを形成しつつあります。本イノベーション解説では、その将来へのビジョンを提示し、拡張性と収益性が高く、レジリエントなバイオプロセスがビジネスと持続可能性にどのように役立つかを説明します。